These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 30817781)

  • 21. Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System.
    Antonazzo IC; Raschi E; Forcesi E; Riise T; Bjornevik K; Baldin E; De Ponti F; Poluzzi E
    Expert Opin Drug Saf; 2018 Sep; 17(9):869-874. PubMed ID: 30058390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs.
    Bohn J; Kortepeter C; Muñoz M; Simms K; Montenegro S; Dal Pan G
    Clin Pharmacol Ther; 2015 May; 97(5):508-17. PubMed ID: 25670505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System.
    Borrelli EP; Lee EY; Descoteaux AM; Kogut SJ; Caffrey AR
    Epilepsia; 2018 Dec; 59(12):2318-2324. PubMed ID: 30395352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Status of Parkinsonism-Related Adverse Events and Associated Drugs in Korea.
    Kim S; Suh HS
    J Patient Saf; 2019 Dec; 15(4):e56-e59. PubMed ID: 28368965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance.
    Aagaard L; Hallgreen CE; Hansen EH
    Int J Obes (Lond); 2016 Nov; 40(11):1742-1747. PubMed ID: 27478924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adverse Event Trends Associated with Over-the-counter Drugs: Data Mining of the Japanese Adverse Drug Event Report Database].
    Umetsu R; Abe J; Ueda N; Kato Y; Nakayama Y; Kinosada Y; Nakamura M
    Yakugaku Zasshi; 2015; 135(8):991-1000. PubMed ID: 26234358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A survey of spontaneous reporting of adverse drug reactions in 10 years of activity in a pharmacovigilance centre in Portugal.
    Marques J; Ribeiro-Vaz I; Pereira AC; Polónia J
    Int J Pharm Pract; 2014 Aug; 22(4):275-82. PubMed ID: 24188533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric medication error reports in Korea adverse event reporting system database, 1989-2012: comparing with adult reports.
    Woo Y; Kim HE; Chung S; Park BJ
    J Korean Med Sci; 2015 Apr; 30(4):371-7. PubMed ID: 25829803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The contribution of direct patient reported ADRs to drug safety signals in the Netherlands from 2010 to 2015.
    van Hunsel F; de Waal S; Härmark L
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):977-983. PubMed ID: 28524293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
    Jose J; Rao PG
    Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Temporal trends in spontaneous reporting of unlabelled adverse drug reactions.
    Haramburu F; Bégaud B; Moride Y
    Br J Clin Pharmacol; 1997 Sep; 44(3):299-301. PubMed ID: 9296328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of data on capecitabine-related adverse drug reactions from the Korean adverse event reporting system database.
    Park JY
    Eur J Oncol Nurs; 2018 Jun; 34():55-60. PubMed ID: 29784139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases.
    Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA
    Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Medicine Withdrawal on Reporting of Adverse Events Involving Therapeutic Alternatives: A Study from the French Spontaneous Reporting Database.
    Pageot C; Bezin J; Smith A; Arnaud M; Salvo F; Haramburu F; Bégaud B; Pariente A;
    Drug Saf; 2017 Nov; 40(11):1099-1107. PubMed ID: 28664354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of patients' experiences with antidepressants reported by means of a medicine reporting system.
    van Geffen EC; van der Wal SW; van Hulten R; de Groot MC; Egberts AC; Heerdink ER
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1193-9. PubMed ID: 17874086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Language does not come "in boxes": Assessing discrepancies between adverse drug reactions spontaneous reporting and MedDRA® codes in European Portuguese.
    Inácio P; Airaksinen M; Cavaco A
    Res Social Adm Pharm; 2015; 11(5):664-74. PubMed ID: 25596069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics, Quality and Contribution to Signal Detection of Spontaneous Reports of Adverse Drug Reactions Via the WEB-RADR Mobile Application: A Descriptive Cross-Sectional Study.
    Oosterhuis I; Taavola H; Tregunno PM; Mas P; Gama S; Newbould V; Caster O; Härmark L
    Drug Saf; 2018 Oct; 41(10):969-978. PubMed ID: 29761281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiotoxicity in targeted therapy for breast cancer: A study of the FDA adverse event reporting system (FAERS).
    Wittayanukorn S; Qian J; Johnson BS; Hansen RA
    J Oncol Pharm Pract; 2017 Mar; 23(2):93-102. PubMed ID: 26661047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in the adverse events associated with cardiovascular drugs in a spontaneous reporting system in South Korea.
    Park HH; Kim JH; Yoon D; Lee H; Shin JY
    Int J Clin Pharm; 2021 Aug; 43(4):1036-1044. PubMed ID: 33439426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.